Inhibiting NKCC1 activity with bumetanide or silencing NKCC1 expression significantly suppressed traumatic brain injury induced intracellular Na+ increase, neuronal apoptosis, brain edema, and improved neurological function (Hui et al., 2016). Here, SLC12A2 is linked to injury.